Who Paid My Doc
Oral Budesonide Suspension Obs in Adolescents and Adult Subjects With Eosinophilic Esophagitis DB, Placebo-Controlled, RW
ClinicalTrials.gov NCT02605837
Research payments
$1,947,519
Through program year 2019, $1,947,519 in research payments was reported against Oral Budesonide Suspension Obs in Adolescents and Adult Subjects With Eosinophilic Esophagitis DB, Placebo-Controlled, RW, across 417 payments, paid by Shire North American Group Inc.
- Paid by
- Shire North American Group Inc
- ClinicalTrials.gov
- NCT02605837
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $1,947,519 | 417 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Yehudith Assouline-Dayan Iowa City, IA Named on 23 payments
- Reed Dimmitt Birmingham, AL Named on 23 payments
- Matthew McBride Oklahoma City, OK Named on 21 payments
- Sam Moussa Tucson, AZ Named on 20 payments
- Robert Murphy North Little Rock, AR Named on 13 payments
- Calies Menard-Katcher Aurora, CO Named on 12 payments
- Mirna Chehade New York, NY Named on 11 payments
- Steven Dellon Dayton, OH Named on 10 payments
- Gary Falk Philadelphia, PA Named on 10 payments
- Steven Harrell New Albany, IN Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.